Valuence Merger I scheduled a May 30 meeting for shareholders to vote on an extension that would give the SPAC until March 2025 to find and complete a deal.
The SPAC raised $200 million in a March 2022 IPO to pursue an acquisition of a life sciences company based in Asia, though excluding China, Hong Kong and Macau.
Valuence I lost more than two-thirds of its shares outstanding to redemptions in connection with the last extension vote a year ago.
CEO and Director Sung Yoon Woo is the founder and CEO of Credian Partners, a private equity firm based in South Korea. Read more.
